Menu
Washingtoner
  • Home
  • Health
  • Technology
  • Artificial Intelligence
  • Real Estate
  • Entertainment
  • Non-profit
  • Longevity
  • Music
Washingtoner

Iohexol Injection of Beilu Pharmaceutical Receives MA in the EU
Washingtoner/10288907

Trending...
  • Continuous You Foundation Announces Partnership with Haawke Neural Technology
  • Tacoma: Applicants Sought for the Board of Ethics
  • Lake Norman Philharmonic - Free Community Concert
Iohexol Injection Of Beilu Pharma Receives MA Beijing Beilu Pharmaceutical Co., Ltd.
MIYUN, China - Washingtoner -- Recently, Beijing Beilu Pharmaceutical Co., Ltd. received the "Marketing Authorization" (MA) issued by the Netherlands Medicines Evaluation Board (MEB) in accordance with the relevant regulations of the European Medicines Agency.

Certificate information:
  • Company name: Beijing Beilu pharmaceutical Co., Ltd.
  • Manufacturing address: No.3 Shuiyuan West Road, Miyun District, Beijing, China
  • Registration number: RVG 132878
  • Drug name: Iohexol injection 350mg(I)/ml
  • Issuing authority: Netherlands Medicines Evaluation Board (MEB)
The successful registration of Iohexol Injection in Netherland indicates that the product has undergone rigorous scientific evaluation by EMA, confirming its compliance with EU Good Manufacturing Practice (GMP), quality, safety and efficacy standards. This authorization enables commercial distribution in EU-approved countries. It creates conditions for speeding up the Mutual recognition procedures(MRP) among EU countries such as Germany, France, Italy and others as well. This will help Beilu Pharmaceutical further promote the expansion of its overseas market and enhance the international market competitiveness of its contrast agent products, which is expected to have a positive impact on the company's operations in the future.

More on Washingtoner
  • Haven Treatment Center Now In-Network with First Choice, Expanding Access to Youth Health
  • Kerri Lawless Introduces New Home-Selling Option for Local Homeowners
  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
  • City of Spokane Launches 'Emergency Streets' Pilot Program

Contact Information:
Beijing Beilu Pharmaceutical Co., Ltd.
https://www.beilupharma.com/
yanglm@beilupharma.com

Contact
Beijing Beilu Pharmaceutical Co., Ltd. 
***@beilupharma.com


Source: Beijing Beilu Pharmaceutical Co., Ltd. 
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Applicants Sought for the Tacoma Arts Commission and the Tacoma Creates Advisory Board
  • Spokane City Council Approves Emergency Tenant Protections
  • HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
  • Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
  • Intelligence Daily Features Veteran Hollywood Producer Kirk Shaw On AI And The Future Of Entertainment
  • OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
  • P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport
  • DONGSHENG Titanium Recycling: Promoting a Closed-Loop Cycle for High-End Titanium Materials
  • TBM Council Establishes TBM as The Business Operating System for AI
  • Spokane: SFD's 8th Annual Kids Jr Firefighter Academy
  • Tacoma Dome Unveils Salish Mural
  • French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service
  • Tacoma: Northbound I-705 Stadium Way Off-Ramp to Close at Noon Today for Emergency Repairs
  • LET US READ Documentary on Dyslexia and Literacy to Screen at TCL Chinese 6 in Hollywood
  • PeopleNTech LLC to Participate in CWS Summit North America 2026
  • Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
  • STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
  • Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
  • Tidy-Up Tacoma Teams Up with Community Partners for Citywide Cleanup Event September 19
  • Lynnwood Heating LLC Helps Homeowners Take Advantage of 2026 Heat Pump Installation Rebates
_catLbl0 _catLbl1

Popular on Washingtoner

  • Popular AI planner Voiset launches version 2.0 and enters MENA at LEAP 2026 with full Arabic support - 229
  • On the Boards: Proform Builds Announce New Construction in Alki, Seattle - 166
  • Diginyze eCommerce ERP Module Creates Single Source of Truth for Enterprise Operations - 153
  • Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism - 142
  • Continuous You Foundation Opens Applications For A 100-year Artist Grant - 133
  • 3ptechies Partners with Coolmuster to Give Away Data Recovery Software Licenses - 123
  • Break the Resume Mold: Career Valet Changes How Executives Hunt for Jobs - 123
  • Tacoma: Applications Now Being Accepted for a Position on the Planning Commission - 121
  • Tacoma: Hylebos Bridge Closed Today for Maintenance Work - 110
  • DuoKey launches the World's First Agentic Crypto Agility Platform - 107

Similar on Washingtoner

  • Haven Treatment Center Now In-Network with First Choice, Expanding Access to Youth Health
  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
  • Longevity Academy Announces J.P. Medved of Longevity Advice as Next Guest in the Longevity Leaders
  • Medcurity Introduces a Better Way for Healthcare and Its Vendors to Build Trust
  • Haven Treatment Center Now In-Network Partnership with Aetna, Expanding Access to Youth Health Care
  • Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
  • Mandeville Pests May Pose Serious Health Risks for Your Family
  • Parents No Longer Have to Wait 3 Weeks for a Sleep Consultant: Nora Talks Tonight, Stays for 5 Days, Costs $89
  • Black Women Living With, and Impacted by, HIV Express Gratitude, Grief, Joy, and Resilience
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute